Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effect of PF-00734200 in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00618007

Public ClinicalTrials.gov record NCT00618007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 5:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of 12-Week Administration Of PF-00734200 To Subjects With Type 2 Diabetes Mellitus And Insufficient Glycemic Control On Metformin Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin

Study identification

NCT ID
NCT00618007
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
289 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jun 26, 2011

2008

United States locations

U.S. sites
69
U.S. states
30
U.S. cities
64
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35205 —
Pfizer Investigational Site Chandler Arizona 85225 —
Pfizer Investigational Site Litchfield Park Arizona 85340 —
Pfizer Investigational Site Phoenix Arizona 85051 —
Pfizer Investigational Site Artesia California 90701 —
Pfizer Investigational Site Cerritos California 90703 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Greenbrea California 94904 —
Pfizer Investigational Site Huntington Beach California 92648 —
Pfizer Investigational Site Los Angeles California 90057 —
Pfizer Investigational Site National City California 91950 —
Pfizer Investigational Site Roseville California 95661 —
Pfizer Investigational Site Valley Village California 91607 —
Pfizer Investigational Site West Covina California 91790 —
Pfizer Investigational Site DeFuniak Springs Florida 32435 —
Pfizer Investigational Site Jacksonville Florida 32205 —
Pfizer Investigational Site Miami Florida 33143 —
Pfizer Investigational Site Miami Florida 33169 —
Pfizer Investigational Site New Port Richey Florida 34652 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Pinecrest Florida 33156 —
Pfizer Investigational Site St. Petersburg Florida 33702 —
Pfizer Investigational Site Conyers Georgia 30094 —
Pfizer Investigational Site Idaho Falls Idaho 83404 —
Pfizer Investigational Site Indianapolis Indiana 46260 —
Pfizer Investigational Site Wichita Kansas 67203 —
Pfizer Investigational Site Lexington Kentucky 40504 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site Scarborough Maine 04074 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Oxon Hill Maryland 20745 —
Pfizer Investigational Site Ann Arbor Michigan 48106 —
Pfizer Investigational Site Bay City Michigan 48706 —
Pfizer Investigational Site Canton Michigan 48187 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Jackson Mississippi 39209 —
Pfizer Investigational Site Picayune Mississippi 39466 —
Pfizer Investigational Site City of Saint Peters Missouri 63376 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site St Louis Missouri 63141 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Elizabeth New Jersey 07202 —
Pfizer Investigational Site Trenton New Jersey 08611 —
Pfizer Investigational Site Albuquerque New Mexico 87106 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Marion Ohio 43302 —
Pfizer Investigational Site Eugene Oregon 97401 —
Pfizer Investigational Site Cumberland Rhode Island 02864 —
Pfizer Investigational Site Aiken South Carolina 29801 —
Pfizer Investigational Site Florence South Carolina 29501 —
Pfizer Investigational Site Kingsport Tennessee 37660 —
Pfizer Investigational Site Dallas Texas 75230 —
Pfizer Investigational Site Dallas Texas 75235 —
Pfizer Investigational Site El Paso Texas 79935 —
Pfizer Investigational Site Houston Texas 77023 —
Pfizer Investigational Site Houston Texas 77081 —
Pfizer Investigational Site Hurst Texas 76054 —
Pfizer Investigational Site Odessa Texas 79761 —
Pfizer Investigational Site Pearland Texas 77584 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Salt Lake City Utah 84107 —
Pfizer Investigational Site Bennington Vermont 05201-5018 —
Pfizer Investigational Site Ettrick Virginia 23803 —
Pfizer Investigational Site Richmond Virginia 23225 —
Pfizer Investigational Site Virginia Beach Virginia 23454 —
Pfizer Investigational Site Virginia Beach Virginia 23455 —
Pfizer Investigational Site Spokane Washington 99208 —
Pfizer Investigational Site Kenosha Wisconsin 53142 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00618007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2011 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00618007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →